Resmed Inc
OTC:RSMDF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Resmed Inc
OTC:RSMDF
|
US |
|
Hong Kong Exchanges and Clearing Ltd
HKEX:388
|
HK |
|
B
|
Bank of America Corp
LSE:0Q16
|
US |
|
A
|
Accuray Inc
F:XEJ
|
US |
|
B
|
BlackRock Inc
SWB:BLQA
|
US |
|
Y
|
Yadea Group Holdings Ltd
OTC:YADGF
|
CN |
|
L
|
Loblaw Companies Ltd
OTC:LBLCF
|
CA |
|
C
|
CITIC Securities Co Ltd
XBER:CI9
|
CN |
|
D
|
DTE Energy Co
XMUN:DGY
|
US |
|
Orthofix Medical Inc
F:OM2
|
US |
|
ARMOUR Residential REIT Inc
F:2AR
|
US |
|
B
|
Banco Santander SA
WSE:SAN
|
ES |
|
C
|
Chevron Corp
SWB:CHV
|
US |
|
W
|
WP Carey Inc
F:WPY
|
US |
|
Pirelli & C SpA
F:2PI
|
IT |
|
C
|
Continental AG
XMUN:CON
|
DE |
Wall St Price Targets
RSMDF Price Targets Summary
Resmed Inc
According to Wall Street analysts, the average 1-year price target for RSMDF is 33.9 USD with a low forecast of 5.65 USD and a high forecast of 43.58 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RSMDF's stock price target?
Price Target
33.9
USD
According to Wall Street analysts, the average 1-year price target for RSMDF is 33.9 USD with a low forecast of 5.65 USD and a high forecast of 43.58 USD.
What is the Revenue forecast for Resmed Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 5 years is 9%.
What is the Operating Income forecast for Resmed Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 5 years is 11%.
What is the Net Income forecast for Resmed Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 5 years is 11%.
